Dyadic International Stock (NASDAQ: DYAI) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 100.09K |
Day Range | - - - |
52 Wk Range | 1.19 - 2.67 |
Market Cap | $46.78M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 0.83% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Dyadic International (NASDAQ:DYAI) through any online brokerage.
Other companies in Dyadic International’s space includes: Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX), Elicio Therapeutics (NASDAQ:ELTX) and BioLine Rx (NASDAQ:BLRX).
There is no analysis for Dyadic International.
Dyadic International has a consensus price target of $3.00.
The stock price for Dyadic International (NASDAQ: DYAI) is $1.44 last updated July 5, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Dyadic International.
Dyadic International’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Dyadic International.
Dyadic International is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.